Cited by 555Cancer survivorship and carePharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Fromme, Erik K., Eilers, Kristine M., Mori, Motomi, Hsieh, Yi-Ching, Beer, Tomasz M.·2004·Journal of Clinical Oncology

DOI 10.1200/jco.2004.03.025

Open this paper in CoChat — free account

Abstract

Purpose: Adverse events in chemotherapy clinical trials are assessed and reported by clinicians, yet clinician accuracy in assessing symptoms has been questioned. We compared patient reporting of eight symptoms using a validated instrument, the European Organization for the Research and Treatment of Cancer Quality-of-Life Questionnaire C30 (QLQ-C30 or QLQ) with physicians' reporting of the same symptoms in the study's adverse events log. Patients and Methods: Thirty-seven men with metastatic, androgen-independent prostate cancer enrolled onto a phase II trial of weekly calcitriol and docetaxel completed the QLQ every 4 weeks for up to 28 weeks. A patient-reported symptom was defined as an increase in a QLQ symptom score by at least 10 points (0 to 100 scale), sustained for at least 4 weeks. A physician-reported symptom was considered present if it was ever documented in the adverse event log. Results: Forty-nine (new or worsened) symptoms were detected by both physician and QLQ, 48 symptoms were detected by the physician alone, and 55 symptoms were detected by the QLQ alone. They agreed on the absence of a symptom in 102 instances of 254 possible opportunities. Their uncorrected agreement was 59.4%, but Cohen's κ, a coefficient of agreement that corrects for chance, was 0.15, indicating only slight agreement. Using the QLQ as the standard, overall physician sensitivity and specificity was 47% and 68%, respectively, although it varied considerably among symptoms. Conclusion: Even in a tightly controlled clinical trial, physician reporting was neither sensitive nor specific in detecting common chemotherapy adverse effects. Tools for collecting patient-reported adverse event data in chemotherapy clinical trials should be developed.

Integrity signals

Registry

Crossref · 10.1200/jco.2004.03.025

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Analysis of serial measurements in medical research.
Matthews, J. N. S., Altman, D. G., Campbell, M. J., & Royston, P. J. (1990) · BMJ · doi:10.1136/bmj.300.6719.230 · Cited by 3,137
High agreement but low Kappa: I. the problems of two paradoxes
Feinstein, A. R., & Cicchetti, D. V. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90158-l · Cited by 3,034
Interpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B. C.-Y., & Pater, J. L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 3,016
The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review
Sprangers, M. A. G., & Aaronson, N. K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90052-o · Cited by 1,076
Untitled work
(1997) · PubMed · Cited by 762
National Institutes of Health State of the Science Conference Statement
(2005) · Sleep · doi:10.1093/sleep/28.9.1049 · Cited by 745
Patient-re ported complications and follow-up treatment after radical prostatectomy
Fowler, F. J., Barry, M. J., Lu‐Yao, G. L., Roman, A., Wasson, J. H., & Wennberg, J. E. (1993) · Urology · doi:10.1016/0090-4295(93)90524-e · Cited by 627

Flagged first, then by citations

Show all 32 references

2 of the 32 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Ingham J, Portenoy RK: The measurement of pain and other symptoms, in Doyle D, Hanks G, MacDonald N (eds): Oxford Textbook of Palliative Medicine (ed 2) . Oxford, Oxford University Press, pp 203,2001-222
Bruera E: Research into symptoms other than pain, in Doyle D, Hanks GWC, MacDonald N (eds): Oxford Textbook of Palliative Medicine (ed 2) . Oxford, Oxford University Press, pp 180,1998
10.1023/A:1008886200225 · DOI

Sorted by citations

Items 201–300 of 551

Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39)
Mody, G. N., Stover, A. M., Wang, M., King‐Kallimanis, B. L., Jansen, J., Henson, S. R., Chung, A. E., Jönsson, M., Bennett, A. V., Smith, A. B., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.09.020 · Cited by 28
Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer
Christodoulou, M., McCloskey, P., Stones, N., Bayman, N., Burt, P. A., Chittalia, A., Harris, M., Lee, L. W., Pemberton, L. S., Sheikh, H., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.07.008 · Cited by 28
Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer
Niska, J. R., Halyard, M. Y., Tan, A. D., Atherton, P. J., Patel, S. H., & Sloan, J. A. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1528-2 · Cited by 28
Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial
Bhattacharya, I. S., Haviland, J., Hopwood, P., Coles, C. E., Yarnold, J. R., Bliss, J. M., & Kirby, A. M. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.01.036 · Cited by 28
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients’ quality of life
Baratelli, C., Turco, C. G. C., Lacidogna, G., Sperti, E., Vignani, F., Marino, D., Zichi, C., Luca, E. D., Audisio, M., Ballaminut, D., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04777-2 · Cited by 28
Clinicians’ knowledge and attitudes towards patient reported outcomes in colorectal cancer care – insights from qualitative interviews
Sibert, N. T., Kowalski, C., Pfaff, H., Wesselmann, S., & Breidenbach, C. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06361-z · Cited by 27
Cutaneous toxicities from targeted therapies used in oncology: Literature review of clinical presentation and management
Huynh-Dagher, S., Blom, A., Chabanol, H., & Funck‐Brentano, E. (2021) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2021.09.009 · Cited by 27
Getting ready for real‐world use of electronic patient‐reported outcomes (ePROs) for patients with cancer: A National Comprehensive Cancer Network ePRO Workgroup paper
Cracchiolo, J. R., Arafat, W., Atreja, A., Bruckner, L. B., Emamekhoo, H., Heinrichs, T., Raldow, A. C., Smerage, J. B., Stetson, P. D., Sugalski, J., et al. (2023) · Cancer · doi:10.1002/cncr.34844 · Cited by 27
Enhancing Therapeutic Decision Making When Options Abound: Toxicities Matter
Kuderer, N. M., & Wolff, A. C. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1903 · Cited by 27
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable
Yap, C., Aiyegbusi, O. L., Alger, E., Basch, E., Bell, J. A., Bhatnagar, V., Cella, D. F., Collis, P., Dueck, A. C., Gilbert, A., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102838 · Cited by 26
Prevention and treatment of oral mucositis in patients with head and neck cancer treated with (chemo) radiation: report of an Italian survey
Bossi, P., Numico, G., Sanctis, V. D., Redda, M. G. R., Reali, A., Belgioia, L., Rocca, M. C., Orlandi, E. M., Airoldi, M., Bacigalupo, A., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2166-7 · Cited by 26
Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life
Weber, D. C., Caparrotti, F., Laouiti, M., & Malek, K. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-79 · Cited by 26
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients
Hakobyan, L., Haaijer‐Ruskamp, F. M., de Zeeuw, D., Dobre, D., & Denig, P. (2011) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-9-83 · Cited by 26
Digital Follow-Up and the Perspective of Patient-Centered Care in Oncology: What’s the PROblem?
Giordano, F. A., Welzel, G., Siefert, V., Jahnke, L., Ganslandt, T., Wenz, F. K., Grosu, A., Heinemann, F. E., & Nicolay, N. H. (2018) · Oncology · doi:10.1159/000495294 · Cited by 26
Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study
Larssen, L., Medhus, A. W., Hjermstad, M. J., Kørner, H., Glomsaker, T. B., Søberg, T., Gleditsch, D., Hovde, Ø., Nesbakken, A., Tholfsen, J. K., et al. (2011) · Surgical Endoscopy · doi:10.1007/s00464-011-1680-7 · Cited by 25
Development of a Symptom Index for Patients with Primary Brain Tumors
Lai, J., Jensen, S. E., Beaumont, J. L., Abernethy, A. P., Jacobsen, P. B., Syrjala, K. L., Raizer, J. J., & Cella, D. F. (2014) · Value in Health · doi:10.1016/j.jval.2013.11.006 · Cited by 25
Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications
Shepshelovich, D., Goldvaser, H., Wang, L., Razak, A. R. A., & Bedard, P. L. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0510-8 · Cited by 25
Incorporating patient‐reported outcomes in dose‐finding clinical trials
Lee, S. M., Lu, X., & Cheng, B. (2019) · Statistics in Medicine · doi:10.1002/sim.8402 · Cited by 25
Effectiveness of telenursing for people with lung cancer at home: A systematic review and meta‐analysis
Harada, T., Shibuya, Y., & Kamei, T. (2022) · Japan Journal of Nursing Science · doi:10.1111/jjns.12516 · Cited by 25
Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation
Fares, C. M., Williamson, T. J., Theisen, M. K., Cummings, A. L., Bornazyan, K., Carroll, J., Spiegel, M. L., Stanton, A. L., & Garon, E. B. (2018) · JCO Clinical Cancer Informatics · doi:10.1200/cci.18.00059 · Cited by 25
The use of patient reported outcome measures (PROMs) in palliative radiotherapy: A topical review
Oldenburger, E., Oldenburger, F. R., Coolbrandt, A., Isebaert, S. F., Neyens, I., Sevenants, A., Audenhove, C. V., & Haustermans, K. M. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.045 · Cited by 25
Subclinical late cardiac toxicity in childhood cancer survivors
Cox, C. L., Rai, S. N., Rosenthal, D. N., Phipps, S., & Hudson, M. M. (2008) · Cancer · doi:10.1002/cncr.23378 · Cited by 25
Different Approaches for Case-Mix Adjustment of Patient-Reported Outcomes to Compare Healthcare Providers—Methodological Results of a Systematic Review
Sibert, N. T., Pfaff, H., Breidenbach, C., Wesselmann, S., & Kowalski, C. (2021) · Cancers · doi:10.3390/cancers13163964 · Cited by 24
Automated health chats for symptom management of head and neck cancer patients undergoing radiation therapy
Ma, D., Orner, D., Ghaly, M. M., Parashar, B., Ames, J. W., Chen, W. C.-Y., Potters, L., & Teckie, S. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105551 · Cited by 24
Patient-Reported Outcomes in Supportive Care
Bateman, E. H., & Keefe, D. M. K. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.03.003 · Cited by 24
Patient-reported outcomes in drug safety evaluation
Basch, E. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp542 · Cited by 24
Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data
Basch, E., & Dueck, A. C. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1193148 · Cited by 24
Advancing the efficiency and efficacy of patient reported outcomes with multivariate computer adaptive testing
Morris, S. B., Bass, M., Lee, M., & Neapolitan, R. E. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocx003 · Cited by 23
DIGITAL THERAPEUTICS IN ONCOLOGY: FINDINGS, BARRIERS AND PROSPECTS. A NARRATIVE REVIEW
Gussoni, G., Ravot, E., Zecchina, M., Recchia, G., Santoro, E., R., A., & Perrone, F. (2022) · Annals of Research in Oncology · doi:10.48286/aro.2022.39 · Cited by 23
Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis
Zhou, X., Wang, W., Chao Hui, Z. H. O. U., Zhu, J., Ding, W., Chen, M., Chen, K., Shi, Y., Chen, X., Kong, F., et al. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.03.007 · Cited by 23
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis
Warsame, R. M., Kumar, S. K., Gertz, M. A., Lacy, M. Q., Buadi, F. K., Hayman, S. R., Leung, N., Dingli, D., Lust, J. A., Lin, Y., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24676 · Cited by 23
Unplanned oncology admissions within 14 days of non-surgical discharge: a retrospective study
Gibson, S., & McConigley, R. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2786-6 · Cited by 23
Urban and Rural Differences
Zhu, Z., Hu, Y., Guo, M., & Williams, A. B. (2019) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000025 · Cited by 22
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience
Albaba, H., Barnes, T. A., Veitch, Z. W. N., Brown, M. C., Shakik, S., Su, S., Naik, H., Wang, T., Liang, M., Cosio, A. P., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0830 · Cited by 22
Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer
Schuurhuizen, C. S. E. W., Marino, P., Braamse, A. M. J., Buffart, L. M., Joly, F., Fizazi, K. S., Habibian, M., Boher, J., Soulie, M., Oudard, S. M., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7069 · Cited by 22
Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide
Lai-Kwon, J. E., Thorner, E. D., Rutherford, C., Crossnohere, N. L., & Brundage, M. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438512 · Cited by 21
Oxycodone combined with opioid receptor antagonists: efficacy and safety
Davis, M. P., Goforth, H. W., & Gamier, P. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.783564 · Cited by 21
Symptoms, unmet need, and quality of life among recent breast cancer survivors
Palmer, S., DeMichele, A. M., Schapira, M. M., Glanz, K., Blauch, A. N., Pucci, D. A., & Jacobs, L. A. (2016) · The Journal of Community and Supportive Oncology · doi:10.12788/jcso.0236 · Cited by 22
Visceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study
Lagrange, A., Decoux, D., Briot, N., Hennequin, A., Coudert, B. P., Desmoulins, I., & Bertaut, A. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.08.003 · Cited by 21
On the receiving end: have patient perceptions of the side-effects of cancer chemotherapy changed since the twentieth century?
Vardy, J. L., Liew, A., Warby, A., Elder, A., Keshet, I., Devine, R. J., Ouliaris, C., Renton, C., Tattersall, M. H. N., & Dhillon, H. M. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06804-1 · Cited by 21
Bridging New Technology Into Clinical Practice With Mobile Apps, Electronic Patient-Reported Outcomes, and Wearables
Dzimitrowicz, H. E., Blakely, L. J., Jones, L. W., & LeBlanc, T. W. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_350550 · Cited by 21
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy
Fiteni, F., Anota, A., Bonnetain, F., Oster, J.-P., Pichon, É., Wislez, M., Dauba, J., Debieuvre, D., Souquet, P.-J., Bigay-Game, L., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01695-2015 · Cited by 21
Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial
Ataseven, B., Frindte, J., Harter, P., Gebers, G., Vogt, C., Traut, A., Breit, E., Bluni, V., Reinisch, M., Heitz, F., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05216-y · Cited by 21
Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in Ethiopia: A Prospective Observational Study
Gadisa, D. A., Assefa, M., Tefera, G. M., & Yimer, G. (2020) · Journal of Oncology · doi:10.1155/2020/2636514 · Cited by 21
Health‐related quality of life with fixed‐duration venetoclax‐obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial
Al‐Sawaf, O., Gentile, B., Devine, J., Zhang, C., Sail, K., Tandon, M., Fink, A., Kutsch, N., Wendtner, C., Eichhorst, B. F., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26260 · Cited by 21
Identification of hand-foot syndrome from cancer patients’ blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms
Nishioka, S., Watanabe, T., Asano, M., YAMAMOTO, T., Kawakami, K., Yada, S., Aramaki, E., Yajima, H., Kizaki, H., & Hori, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267901 · Cited by 21
A prospective study of patient-centred outcomes in the management of malignant pleural effusions
Walker, S., Zubrinic, M., Massey, C., Shargall, Y., Bédard, E. L. R., & Darling, G. E. (2016) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2016.22.7.351 · Cited by 20
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer
Generalova, O., Roy, M., Hall, E. T., Shah, S. A., Cunanan, K. M., Fardeen, T., Velazquez, B., Chu, G., Bruzzone, B., Cabot, A., et al. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00358-2 · Cited by 20
Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
Basch, E., Charlot, M., & Dueck, A. C. (2020) · Cancer Medicine · doi:10.1002/cam4.3480 · Cited by 20
Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study
Kanagalingam, J., Wahid, M. I. A., Lin, J., Cupino, N., Liu, E., Kang, J., Bazarbashi, S. N., Moreira, N. B., Arumugam, H., Mueller, S., et al. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4050-3 · Cited by 19
Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population
Ludwig, H., Pönisch, W., Knop, S. T., Egle, A., Hinke, A., Schreder, M., Lechner, D., Hájek, R., Gunsilius, E., Petzer, A. L., et al. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1666381 · Cited by 19
Patient-Reported Outcomes in Phase 3 Clinical Trials for Blood Cancers: A Systematic Review
Patel, K. K., Ivanov, A., Jocelyn, T., Hantel, A., Garcia, J. S., & Abel, G. A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.14425 · Cited by 22
Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy
Mackler, E. R., Petersen, L., Severson, J. A., Blayney, D. W., Benitez, L. L., Rausch, C. R., Hough, S. M., & Griggs, J. J. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.018390 · Cited by 19
Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials
Sedhom, R., FERRELL, B. R., Ruel, N. H., Koczywas, M., Chung, V. M., & Smith, T. J. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa067 · Cited by 19
Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702
Lee, S., Ma, C., Shi, Q., Kumar, P., Couture, F., Kuebler, P. J., Krishnamurthi, S., Lewis, D. A., Tan, B., Goldberg, R. M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01637 · Cited by 19
Assessment of Multiple Co-Occurring Cancer Symptoms in the Clinical Setting
Cooley, M. E., & Siefert, M. L. (2016) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2016.08.003 · Cited by 19
In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'
Force, T. L. (2007) · Nature Medicine · doi:10.1038/nm0107-15b · Cited by 19
Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review
Colomer‐Lahiguera, S., Bryant‐Lukosius, D., Rietkoetter, S., Martelli, L., Ribi, K., Fitzpatrick‐Lewis, D., Sherifali, D., Orcurto, A., Juergens, R. A., & Eicher, M. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00210-z · Cited by 18
Symptoms and Needs Monitoring in Diverse Ambulatory Oncology Patients: Usage Characteristics and Impact on Emergency Room Visits and Hospitalization
Natori, A., Sookdeo, V. D., Koru‐Sengul, T., Schlumbrecht, M. P., Calfa, C. L., Maclntyre, J., Benzo, R. M., Moreno, P. I., Crane, T. E., Garcia, S. F., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.01038 · Cited by 18
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment.
Keller, S., Seipel, K., Novak, U., Mueller, B., Taleghani, B. M., Leibundgut, K., & Pabst, T. (2015) · Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis · doi:10.1016/j.leukres.2015.03.015 · Cited by 18
Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data
Mandelblatt, J. S., Huang, K., Makgoeng, S. B., Luta, G., Song, J., Tallarico, M., Roh, J. M., Munneke, J. R., Houlston, C. A., McGuckin, M., et al. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2013.001288 · Cited by 18
Development of an eHealth System to Capture and Analyze Patient Sensor and Self-Report Data: Mixed-Methods Assessment of Potential Applications to Improve Cancer Care Delivery
Lucas, A. R., Bass, M., Rothrock, N. E., O'Connor, M. L., Sorkin, M., Nawyn, J., Albinali, F., & Wagner, L. I. (2018) · JMIR Medical Informatics · doi:10.2196/medinform.9525 · Cited by 18
Quality of life issues in relation to the aromatase inhibitor
Fallowfield, L. J. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.003 · Cited by 18
Palifermin in Prevention of Head and Neck Cancer Radiation-Induced Mucositis: Not Yet a Definitive Word on Safety and Efficacy Profile
Bossi, P., Locati, L. D., & Licitra, L. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.1136 · Cited by 18
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials
Arenare, L., Liello, R. D., Placido, P. D., Gridelli, C., Morabito, A., Pignata, S., Nuzzo, F., Avallone, A., Maiello, E., Gargiulo, P., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.102941 · Cited by 17
Rôle et utilisation des Patient reported outcomes (PROs) dans la prise en charge des patients en oncologie
Marino, P., Bannier, M., Moulin, J.-F., & Gravis, G. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2018.02.008 · Cited by 22
Exploration of baseline patient-reported side effect bother from cancer therapy
Roydhouse, J. K., King‐Kallimanis, B. L., Roy, P., Weinstock, C., Krol, D., Daniels, S. R., Suzman, D. L., Beaver, J. A., & Kluetz, P. G. (2020) · Clinical Trials · doi:10.1177/1740774520910389 · Cited by 17
Enhancing Outpatient Symptom Management in Patients With Head and Neck Cancer
Noel, C. W., Du, Y. J., Baran, E., Forner, D. W. A., Husain, Z. A., Higgins, K. M., Karam, I., Chan, K., Hallet, J. I., Wright, F. C., et al. (2022) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2021.4555 · Cited by 17
Patient Use of Electronic Methods to Self-Report Symptoms: An Integrative Literature Review
Carrasco, S., & Symes, L. (2018) · Oncology nursing forum · doi:10.1188/18.onf.399-416 · Cited by 17
„Patient-reported outcomes“ in der onkologischen Versorgung – aktuelle Anwendungsfelder und Initiativen der Deutschen Krebsgesellschaft
Kowalski, C., Wesselmann, S., van Oorschot, B., Alt‐Epping, B., Breidenbach, C., Sibert, N. T., Fischer, F. H., Käsmann, L., Karger, A., Karsten, M. M., et al. (2024) · Die Onkologie · doi:10.1007/s00761-024-01508-z · Cited by 16
Comparing Adverse Event Rates of Oral Blood Glucose-Lowering Drugs Reported by Patients and Healthcare Providers
Hakobyan, L., Haaijer‐Ruskamp, F. M., de Zeeuw, D., Dobre, D., & Denig, P. (2011) · Drug Safety · doi:10.2165/11593810-000000000-00000 · Cited by 16
Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole
Yagata, H., Ohtsu, H., Komoike, Y., Saji, S., Takei, H., Nakamura, T., Ohashi, Y., Iwase, T., & Shimozuma, K. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2830-6 · Cited by 16
Trending Longitudinal Agreement between Parent and Child Perceptions of Quality of Life for Pediatric Palliative Care Patients
Weaver, M. S., Darnall, C., Bace, S., Vail, C., Macfadyen, A. J., & Wichman, C. (2017) · Children · doi:10.3390/children4080065 · Cited by 16
Exploring Relationships between Body Appreciation and Self-Reported Physical Health among Young Women
Winter, V. R., O’Neill, E. A., & Omary, A. (2017) · Health & Social Work · doi:10.1093/hsw/hlx006 · Cited by 18
Cardiovascular and Metabolic Toxicity of Abiraterone in Castration-resistant Prostate Cancer: Post-marketing Experience
Tsao, P. A., Estes, J. P., Griggs, J. J., Smith, D. C., & Caram, M. E. V. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.03.001 · Cited by 16
Adverse event reporting in oncology clinical trials - lost in translation?
Sivendran, S., & Galsky, M. D. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1175429 · Cited by 16
Examining patient-reported late toxicity and its association with quality of life and unmet need for symptom management among nasopharyngeal cancer survivors: a cross-sectional survey
Tam, V. C. W., Ching, J. C. F., Yip, S. S. T., Kwong, V. H. Y., Chan, C. P. L., Wong, K. C. W., & Lee, S. W. Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1378973 · Cited by 15
Analysis of Factors Associated with Patient or Caregiver Regret following Surgery for Fecal Incontinence
Meenakshi‐Sundaram, B., Coco, C. T., Furr, J. R., Dubow, B. P., Aston, C. E., Lewis, J. V., Slobodov, G., Kropp, B. P., & Frimberger, D. C. (2017) · The Journal of Urology · doi:10.1016/j.juro.2017.07.040 · Cited by 15
The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy
Pituskin, E., Paterson, D. I., Cox-Kennett, N., Rothe, D., Perri, M., & Becher, H. H. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.08.010 · Cited by 15
Long-Term Patient-Reported Rectal Bleeding and Bowel-Related Quality of Life After Cs-131 Prostate Brachytherapy
Ling, D. C., Chen, K. S., Benoit, R. M., Beriwal, S., & Smith, R. P. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.02.056 · Cited by 15
Health-Related Quality of Life and Patient-Reported Outcomes in Radiation Oncology Clinical Trials
Remick, J. S., Kowalski, E. S., Samanta, S., Choi, S. W., Palmer, J. D., & Mishra, M. V. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00782-4 · Cited by 15
International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials
Brady, K. J. S., Peipert, J. D., Atkinson, T. M., Pompili, C., Pinto, M., Shaw, J. W., & Roydhouse, J. K. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03396-z · Cited by 15
Computerized patient-reported symptom assessment in radiotherapy: a pilot randomized, controlled trial
Fromme, E. K., Holliday, E. B., Nail, L. M., Lyons, K. S., Hribar, M. R., & Thomas, C. R. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2983-3 · Cited by 15
Self-citation
Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer
Berman, A. T., DeCesaris, C. M., Simone, C. B., Vachani, C. C., DiLullo, G. A., Hampshire, M. K., Metz, J. M., & Hill‐Kayser, C. E. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2015.008904 · Cited by 15
Patients’ perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study
Brédart, A., Bodson, S., Tourneau, C. L., Flahault, C., Bonnetain, F., Beaudeau, A., Coquan, E., Dolbeault, S., & Paolettí, X. (2016) · European Journal of Cancer Care · doi:10.1111/ecc.12596 · Cited by 15
Development and validation of a patient-reported questionnaire assessing systemic therapy induced diarrhea in oncology patients
Lui, M., Gallo-Hershberg, D., & DeAngelis, C. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0794-6 · Cited by 15
Could existing infrastructure for using patient‐reported outcomes as quality measures also be used for individual care in patients with colorectal cancer?
Breidenbach, C., Kowalski, C., Wesselmann, S., & Sibert, N. T. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06457-6 · Cited by 15
A tailored phase I-specific patient-reported outcome (PRO) survey to capture the patient experience of symptomatic adverse events
van Rensburg, H. J. J., Liu, Z., Watson, G. A., Veitch, Z. W. N., Shepshelovich, D., Spreafico, A., Razak, A. R. A., Bedard, P. L., Siu, L. L., Minasian, L. M., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02307-w · Cited by 16
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App
Smith, K. L., Tsai, H., Lim, D., Wang, C., Nunes, R., Wilkinson, M. J., Sheng, J. Y.-S., Couzi, R. J., Fetting, J. H., Riley, C. D., et al. (2023) · JCO Oncology Practice · doi:10.1200/op.23.00038 · Cited by 15
Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Wang, T. Q., Samuel, J. N., Brown, M. C., Vennettilli, A., Solomon, H., Eng, L., Liang, M., Gill, G., Merali, Z., Tian, C., et al. (2018) · Oncology and Therapy · doi:10.1007/s40487-018-0065-7 · Cited by 15
Immunotherapy induced enterocolitis and gastritis – What to do and when?
Cheung, V., & Brain, O. (2020) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2020.101703 · Cited by 14
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer
Singhal, U., Skolarus, T. A., Gore, J. L., Parry, M. G., Chen, R. C., Nossiter, J., Cruz, A. P., George, A. K., Cathcart, P. J., van der Meulen, J., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00575-4 · Cited by 14
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer
Kristensen, A. K., Grønberg, B. H., Fløtten, Ø., Kaasa, S., & Solheim, T. S. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07359-x · Cited by 14
Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer
Wages, N. A., Nelson, B. A., Kharofa, J. R., & Meier, T. M. (2022) · The International Journal of Biostatistics · doi:10.1515/ijb-2022-0023 · Cited by 14
Oral Information About Side Effects of Endocrine Therapy for Early Breast Cancer Patients at Initial Consultation and First Follow-Up Visit: An Online Survey
Luschin, G., & Habersack, M. (2013) · Health Communication · doi:10.1080/10410236.2012.743096 · Cited by 14
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma
Fukushi, K., Narita, T., Hatakeyama, S., Yamamoto, H., Tobisawa, Y., Yoneyama, T., Yoneyama, T., Hashimoto, Y., Koie, T., & Οhyama, C. (2017) · International Journal of Urology · doi:10.1111/iju.13318 · Cited by 14
Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trial
Salehi, S., Åvall-Lundqvist, E. H., Brandberg, Y., Johansson, H., Suzuki, C., & Falconer, H. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2018-000019 · Cited by 14
Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study
Veldhuijzen, E., Walraven, I., & Belderbos, J. S. A. (2021) · JMIR Cancer · doi:10.2196/26574 · Cited by 14
SIOG (International Society of Geriatric Oncology) Recommendations for Anthracycline Use in the Elderly
Aapro, M. (2011) · Hematology Reports · doi:10.4081/hr.2011.s3.e6 · Cited by 14
Implementation of Symptom Questionnaires Into Oncology Workflow
Stover, A. M., & Basch, E. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.015610 · Cited by 14

Authors: Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M.
Affiliations: Oregon Health & Science University (US)
Corresponding author: Beer, Tomasz M.
ORCID: Fromme, Erik K.
Mori, Motomi
Beer, Tomasz M.
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2004-09-01
Volume: 22
Issue: 17
Pages: 3485-3490
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2004.03.025
OpenAlex: W2150906637
Cited by: 555
References: 32
Citations by year: 2026: 12 · 2025: 15 · 2024: 40 · 2023: 35 · 2022: 56 · 2021: 41 · 2020: 45 · 2019: 34 · 2018: 38 · 2017: 44 · 2016: 32 · 2015: 32 · 2014: 17 · 2013: 17 · 2012: 14
FWCI: 4.16
Type: journal article
Language: en
Open access: closed
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30 CA 69533, P30CA069533)
National Center for Research Resources (3 M01RR00334-33S2, M01RR000334)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords: chemotherapy side effects, patient-reported symptoms, EORTC QLQ-C30, castration-resistant prostate cancer, metastatic prostate cancer, docetaxel, 1,25-dihydroxyvitamin D3, adverse event reporting, quality of life assessment
MeSH terms: Antineoplastic Combined Chemotherapy Protocols, Humans, Male, Physicians, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Adverse Drug Reaction Reporting Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks